You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Asthma frequently asked questions

This page is specifically for patients who have been prescribed Relvar Ellipta. If you are not a patient please return to the public website.

  • How can I keep doing exercise and playing sports?

    To reduce your risk of symptoms when playing sports, increase your exercise level gradually through a fitness programme with the aim of exercising freely at your optimum level.

    Remember to always have your quick-acting reliever inhaler (usually blue) with you when exercising, be aware of other triggers such as pollen, and follow the advice from your doctor or nurse in terms of how and when to use your quick-acting reliever inhaler.[1]

  • Can sex bring on asthma symptoms?

    Yes. In one survey of people who had made asthma-related visits to hospital, nearly 60% said their sexual activity was limited by their asthma. You can control your symptoms better by taking your quick-acting reliever inhaler (usually blue) beforehand and making sure you take your preventer inhaler regularly. As with sports, you can improve your overall fitness with incremental intensity in your workouts. If you have any queries or concerns please talk to your doctor or nurse – they won’t be embarrassed and neither should you.[2]

  • How can I manage my triggers?

    Here are some links that provide practical advice from MyAsthma and the Asthma UK charity website to help you manage the triggers that affect you:

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at .
By reporting side effects you can help provide more information on the safety of this medicine.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies